Cytokine-directed therapy in asthma

Current Drug Targets. Inflammation and Allergy
Masakazu Ichinose, Peter J Barnes

Abstract

Increasing evidence of the pathological roles of multiple cytokines in orchestrating and perpetuating inflammation in asthma has prompted the evaluation of novel anti-cytokine therapies. Anti-IL-5 antibody markedly reduces peripheral blood and airway eosinophils, but does not appear to be effective in symptomatic asthma. Inhibition of IL-4, despite promising early results in asthma has been discontinued and blocking IL-13 might be more effective. Inhibitory cytokines, such as IL-10, interferons and IL-12 are less promising, as systemic delivery produces side effects. Inhibition of TNF-alpha may be useful in severe asthma. Agents that target IL-13 are still early in the development process. Many chemokines are involved in the inflammatory response of asthma and several small molecule inhibitors of chemokine receptors are in development. CCR3 antagonists, which block eosinophil chemotaxis, are in clinical development for asthma therapy. Because so many cytokines are involved in asthma, drugs that inhibit the synthesis of multiple cytokines may prove to be more useful; several such classes of drug are now in clinical development and any risk of side effects with these non-specific inhibitors may be reduced by the inhaled route.

Citations

Jun 22, 2005·The Journal of Experimental Medicine·Joshua A Boyce, K Frank Austen
Sep 19, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mohamed Labib SalemDavid J Cole
Jul 19, 2005·Cancer Research·Judith SchwartzbaumMaria Feychting
Apr 15, 2006·American Journal of Respiratory and Critical Care Medicine·Takumi KiwamotoKiyohisa Sekizawa
Feb 10, 2007·American Journal of Respiratory and Critical Care Medicine·Ariel MunitzFrancesca Levi-Schaffer
Mar 10, 2008·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Masakazu Ichinose
Mar 25, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chih-Cheng ChuangWen-Yuan Du
Jun 14, 2005·Expert Opinion on Therapeutic Targets·Ruo-Pan HuangRuochun Huang
May 1, 2010·International Immunopharmacology·Rama MalaviyaRavi Malaviya
Mar 1, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C HerbertR K Kumar
Feb 7, 2006·European Journal of Pharmacology·Toshiyuki Yamagata, Masakazu Ichinose
Oct 1, 2013·Experimental Parasitology·Wen-Yuan DuChih-Cheng Chuang
Dec 17, 2005·Current Opinion in Pulmonary Medicine·Esteban J Morcillo, Julio Cortijo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.